Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Auto-injector is a medical device designed to deliver a dose of a particular drug.
Most auto-injectors are spring-loaded syringes. By design, auto-injectors are easy to use and are intended for self-administration by patients, or administration by untrained personnel. The site of injection depends on the drug loaded, but it typically is administered into the thigh or the buttocks.
Auto-Injectors are expected to present vast opportunities to investors due to high demand in biologics development. Overall revenues from the pre-filled syringes segment is expected to grow during the forecast period due to the rising need for targeted and sustained drug delivery.
The global average price of Auto-Injectors is in the increasing trend from 2013-2016, Auto-injectors manufacturers are introducing generic versions in order to reduce the overall cost of the device. In order to better serve anaphylaxis patients with epinephrine at an affordable cost, Mylan N.V. has implemented the decision of introducing the generic version of Epipen at half the price.
Market Analysis and Insights: Global Auto-Injectors Market
The global Auto-Injectors market was valued at US$ 2244.5 in 2020 and will reach US$ 3463.9 million by the end of 2027, growing at a CAGR of 7.5% during 2022-2027.
Global Auto-Injectors Scope and Market Size
The global Auto-Injectors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Auto-Injectors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Disposable Auto-Injectors
Reusable Auto-Injectors
Segment by Application
Anaphylaxis
Multiple Sclerosis
Rheumatoid Arthritis
Others
The Auto-Injectors market is analysed and market size information is provided by regions (countries). Segment by Application, the Auto-Injectors market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Mylan
BD
Johnson & Johnson
Amgen Inc.
Eli Lilly
Biogen Idec
Bayer
Meridian (Pfizer)
Ypsomed Holding
Kaleo, Inc.
Owen Mumford
Antares Pharma, Inc.
Medeca Pharma AB
Most auto-injectors are spring-loaded syringes. By design, auto-injectors are easy to use and are intended for self-administration by patients, or administration by untrained personnel. The site of injection depends on the drug loaded, but it typically is administered into the thigh or the buttocks.
Auto-Injectors are expected to present vast opportunities to investors due to high demand in biologics development. Overall revenues from the pre-filled syringes segment is expected to grow during the forecast period due to the rising need for targeted and sustained drug delivery.
The global average price of Auto-Injectors is in the increasing trend from 2013-2016, Auto-injectors manufacturers are introducing generic versions in order to reduce the overall cost of the device. In order to better serve anaphylaxis patients with epinephrine at an affordable cost, Mylan N.V. has implemented the decision of introducing the generic version of Epipen at half the price.
Market Analysis and Insights: Global Auto-Injectors Market
The global Auto-Injectors market was valued at US$ 2244.5 in 2020 and will reach US$ 3463.9 million by the end of 2027, growing at a CAGR of 7.5% during 2022-2027.
Global Auto-Injectors Scope and Market Size
The global Auto-Injectors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Auto-Injectors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Disposable Auto-Injectors
Reusable Auto-Injectors
Segment by Application
Anaphylaxis
Multiple Sclerosis
Rheumatoid Arthritis
Others
The Auto-Injectors market is analysed and market size information is provided by regions (countries). Segment by Application, the Auto-Injectors market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Mylan
BD
Johnson & Johnson
Amgen Inc.
Eli Lilly
Biogen Idec
Bayer
Meridian (Pfizer)
Ypsomed Holding
Kaleo, Inc.
Owen Mumford
Antares Pharma, Inc.
Medeca Pharma AB
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
